Pages that link to "Q72275131"
Jump to navigation
Jump to search
The following pages link to Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea (Q72275131):
Displaying 50 items.
- Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer (Q24795784) (← links)
- Molecular Insights into Microbial -Glucuronidase Inhibition to Abrogate CPT-11 Toxicity (Q27678202) (← links)
- Camptothecins: a review of their chemotherapeutic potential (Q28203339) (← links)
- Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study (Q33342696) (← links)
- Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer (Q33345397) (← links)
- Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer (Q33348261) (← links)
- Phase II Trial of Irinotecan (CPT-11) in Relapsed or Refractory Non-Hodgki n's Lymphomas (Q33357201) (← links)
- Single-Agent Irinotecan as Second-Line Treatment for Advanced Gastric Cancer (Q33357475) (← links)
- Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study (Q33362772) (← links)
- A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer (Q33746097) (← links)
- Old drug new use--amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity (Q33838603) (← links)
- Management of cancer treatment-related diarrhea. Issues and therapeutic strategies (Q33853089) (← links)
- A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors (Q33924277) (← links)
- Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (Q34257664) (← links)
- Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer (Q34289631) (← links)
- Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients (Q34343973) (← links)
- Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. (Q34512245) (← links)
- Understanding and modulating mammalian-microbial communication for improved human health (Q35026463) (← links)
- The camptothecins. (Q35169644) (← links)
- Prevention of chemotherapy and radiation toxicity with glutamine. (Q35571238) (← links)
- Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial (Q35623301) (← links)
- Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea (Q35840388) (← links)
- Mammalian carboxylesterases: from drug targets to protein therapeutics (Q36062689) (← links)
- A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group (Q36114656) (← links)
- Prevention of irinotecan associated diarrhea by intestinal alkalization. A pilot study in gastrointestinal cancer patients (Q36464014) (← links)
- Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model (Q36518832) (← links)
- Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects (Q36619832) (← links)
- Phase I study of irinotecan and raltitrexed in patients with advanced gastrointestinal tract adenocarcinoma (Q36621705) (← links)
- Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours (Q36648316) (← links)
- Emerging drug treatments for solid tumours (Q36811466) (← links)
- Pharmacogenomics in colorectal cancer: the first step for individualized-therapy (Q36996329) (← links)
- Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancer (Q37235047) (← links)
- Gastrointestinal complications of oncologic therapy (Q37305399) (← links)
- Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation. (Q37697523) (← links)
- The Gastrointestinal Complications of Oncologic Therapy (Q37800677) (← links)
- Diagnosis and management of gastrointestinal complications in adult cancer patients: evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). (Q38080794) (← links)
- Guidance on the management of diarrhoea during cancer chemotherapy (Q38245875) (← links)
- Involvement of Specific Transport System on Uptake of Lactone Form of SN-38 in Human Intestinal Epithelial Cell Line Caco-2 (Q39416673) (← links)
- CPT-11 (Irinotecan) in the treatment of colorectal cancer (Q40423824) (← links)
- A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma (Q40589100) (← links)
- New drugs in the treatment of colorectal carcinoma (Q40845274) (← links)
- Experimental chemotherapeutic agents for the treatment of colorectal carcinoma (Q40886133) (← links)
- Promising new agents in the treatment of non-small cell lung cancer (Q40969505) (← links)
- Photoswitchable particles for on-demand degradation and triggered release (Q41335721) (← links)
- Rapid deconjugation of SN-38 glucuronide and adsorption of released free SN-38 by intestinal microorganisms in rat. (Q42180635) (← links)
- Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen (Q42597856) (← links)
- Current perspectives on camptothecins in cancer treatment (Q42715927) (← links)
- Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors (Q42804296) (← links)
- A phase II study of irinotecan in patients with advanced hepatocellular carcinoma (Q43517150) (← links)
- Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma (Q43542121) (← links)